DEF 14AThe Ballot
Taysha Gene Therapies, Inc. files DEF 14A
Filed Apr 29, 2021 · 5y ago · Accession 0001193125-21-140758
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- DEF 14A
- Filing date
- Apr 29, 2021
- Report date
- Jun 17, 2021
- Document
- d122001ddef14a.htm
- Size
- 704 KB